EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography

Gwang Jun Kim, Ji Su Seong, Jin A Oh

Obstetrics & Gynecology Science · 15.01.2023 · 66 (1) · 1-10

DOI: 10.5468/ogs.22263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.01.2023. Verfasst von Gwang Jun Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The two main screening tests during pregnancy are those for chromosomal abnormalities and neural tube defects (NTDs). In particular, for NTDs, measurement of maternal serum alpha-fetoprotein (MSAFP) levels early in the second trimester (15-18 weeks of gestation) has been considered the gold standard screening test for the past 4 decades. However, with remarkable technological advancements and the widespread use of ultrasound during those periods, mid-trimester ultrasonography has gradually replaced the role of measuring MSAFP levels as a screening method for NTDs. This change was initiated more about 10 years ago in some countries, which have issued national guidelines to use mid-trimester ultrasonography instead of measuring MSAFP levels as a prenatal screening method for NTDs. However, no significant changes have occurred in Korea, where second-trimester ultrasonography is routinely performed with high-quality equipment. We aimed to provide information regarding the importance of changing the screening method for NTDs from MSAFP measurement to ultrasonography, and to detail methods of implementing mid-trimester ultrasonography for screening purposes. We also share our experience of operating a prenatal diagnostic program for NTDs without using MSAFP for more than 15 years.

Schlagwörter

Stichwörter der Autor:innen

Alpha-fetoproteinNeural tube defectsUltrasonography

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.

Zitieren

APA

Kim, G. J., Seong, J. S., & Oh, J. A. (2023). Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science, 66(1), 1-10. https://doi.org/10.5468/ogs.22263

Vancouver

Kim GJ, Seong JS, Oh JA. Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography. Obstetrics & Gynecology Science. 2023;66(1):1-10. doi:10.5468/ogs.22263

BibTeX
@article{Kim2023,
  author = {Kim, Gwang Jun and Seong, Ji Su and Oh, Jin A},
  title = {Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography},
  journal = {Obstetrics & Gynecology Science},
  year = {2023},
  volume = {66},
  number = {1},
  pages = {1--10},
  doi = {10.5468/ogs.22263}
}
Kostenlos starten →